市場調查報告書
商品編碼
1603779
到 2030 年牙科移植骨替代物市場預測:按產品、材料、形式、應用、最終用戶和地區進行的全球分析Dental Bone Graft Substitutes Market Forecasts to 2030 - Global Analysis By Product, Material, Form, Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球牙科移植骨替代物市場規模將達到13.5億美元,並在預測期內以9.7%的複合年成長率成長,到2030年將達到21.7億美元。
牙科移植骨替代物是用於促進骨質缺乏、受損或吸收區域的骨再生和癒合的生物材料。這些替代品可作為新骨生長的支架,有助於人工植牙、牙周病修復和下顎骨重組。這些替代品提供了一致性、易用性和結構支撐,使其在現代牙科和顎顏面手術中恢復骨量和密度方面發揮著重要作用。
根據《國際牙科論壇報》2021 年 6 月發表的報導,許多患者正在要求植入治療,這是骨移植生長的一個有希望的指標。
口腔健康意識不斷增強
隨著人們越來越了解維持牙齒和牙齦健康的重要性,預防性治療也越來越受到關注,包括植入、牙周手術和骨頭移植術。這種認知導致對牙科移植骨替代物,這對於恢復骨量和支撐植入至關重要。此外,對先進治療方案的了解不斷增加,導致患者選擇更有效、更長期的解決方案,推動市場成長。
併發症的風險
牙科移植骨替代物的併發症風險,例如感染疾病、移植物排斥和骨整合不足,可能會阻止患者選擇該手術。這些併發症可能導致癒合延遲、需要額外手術或治療結果不佳。因此,患者可能不願意接受移植手術,這可能會對替代品的需求產生負面影響。對副作用和術後挑戰的恐懼阻礙了市場的成長,尤其是在高風險族群中。
改善醫療基礎設施
設備齊全的牙科診所、專業的設施和訓練有素的專業人員可以讓患者得到更有效、更及時的治療。這有助於引入先進的牙科治療方法,包括植入和骨移植。此外,加強基礎設施將促進創新植入材料的研究和開發並改善治療效果。隨著醫療保健系統的現代化,人們對口腔健康的認知不斷提高,導致對移植骨替代物的需求增加,進一步推動市場擴張。
治療費用高
牙科移植骨替代物的高治療成本是由於所使用的先進材料(合成骨、同種異體移植物、異質骨移植等)、複雜的程序以及對熟練專業人員的需求造成的。這些費用包括移植材料、手術過程和術後護理的價格。這些經濟負擔限制了可近性,特別是對於發展中地區和未投保的患者。因此,許多患者推遲或避免治療,阻礙了市場成長。
COVID-19 的影響
COVID-19 大流行擾亂了供應鏈、推遲了選擇性牙科手術並限制了患者獲得牙科護理的機會,從而對牙科移植骨替代物市場產生了重大影響。封鎖和健康問題在短期內減少了對牙科治療(包括骨移植)的需求。然而,隨著情況的改善和牙科診所恢復正常業務,由於口腔衛生意識的提高和擇期手術的恢復,對骨移植的需求回升。
預計同種異體骨替代品市場在預測期內將是最大的
預計同種異體移植骨替代物細分市場將在整個預測期內獲得最大的市場佔有率。同種異體骨替代物是從人體屍體骨中提取的材料,通常經過處理以去除活細胞以降低免疫排斥的風險。它在各種整形外科手術和牙科治療(例如人工植牙和下顎骨重組)中用作新骨的支架。使用同種異體移植物可以減少額外手術的需要和供體部位的發生率。
預計人工植牙細分市場在預測期內複合年成長率最高。
預計人工植牙細分市場在預測期內複合年成長率最高。在人工植牙領域,移植骨替代物已被證明可以透過為骨不足或受損區域的植入植入提供結構支撐來提高人工植牙的成功率。在植入治療中使用移植骨替代物對於改善因創傷、牙周病或先天性缺陷而導致骨質流失的患者的治療效果以及提高整體植入成功率至關重要。
由於人們對牙科保健意識的提高、可支配收入的增加和人口老化的加劇,預計亞太地區將在預測期內創下最大的市場佔有率。印度、中國和日本等國家由於患者人數眾多且獲得先進牙科護理的機會有所改善,因此成為主要貢獻者。此外,政府的舉措和創新生醫材料的採用預計將在未來幾年推動該地區的市場擴張。
由於對植入的需求不斷增加以及牙科疾病的高發生率,預計北美在預測期內的複合年成長率最高。該地區受益於先進的醫療基礎設施、廣泛的口腔健康意識和高可支配收入。尤其是美國,其對合成骨和同種異體骨等創新骨移植材料的強勁需求引領市場。此外,微創牙科手術的採用和生物材料的技術進步預計將推動北美市場的成長。
According to Stratistics MRC, the Global Dental Bone Graft Substitutes Market is accounted for $1.35 billion in 2024 and is expected to reach $2.17 billion by 2030 growing at a CAGR of 9.7% during the forecast period. Dental bone graft substitutes are biomaterials used to promote bone regeneration and healing in areas where bone is insufficient, damaged, or resorbed. These substitutes serve as a scaffold for new bone growth, aiding in dental implant placement, periodontal repairs, and jaw reconstruction. They offers compatibility, ease of use, and structural support, making them essential in modern dental and maxillofacial procedures for restoring bone volume and density.
According to the article published by Dental Tribune International in June 2021, a large volume of patients demanded an implant procedure, which is a promising indicator for the growth of bone grafting.
Rising awareness of oral health
As people become more informed about the importance of maintaining healthy teeth and gums, there is an increased focus on preventive care, including dental implants, periodontal surgeries, and bone grafting procedures. This awareness leads to higher demand for dental bone graft substitutes, as they are essential for restoring bone volume and supporting implants. Additionally, greater knowledge of advanced treatment options drives patients to choose more effective, long-term solutions, thereby fueling market growth.
Risk of complications
The risk of complications in dental bone graft substitutes, such as infections, graft rejection, or insufficient bone integration, can deter patients from opting for the procedure. These complications may lead to delayed healing, the need for additional surgeries, or poor treatment outcomes. As a result, patients may hesitate to undergo grafting procedures, negatively impacting demand for substitutes. The fear of adverse effects and post-surgical challenges, especially among risk-prone individuals, hampers the market growth.
Improved healthcare infrastructure
With better-equipped dental clinics, specialized facilities, and trained professionals, patients can receive more effective and timely treatments. This fosters the adoption of advanced dental procedures, including dental implants and bone grafting. Additionally, enhanced infrastructure promotes research and development of innovative grafting materials, improving treatment outcomes. As healthcare systems modernize, there is greater awareness of oral health, leading to increased demand for bone graft substitutes, further driving market expansion.
High treatment costs
High treatment costs in dental bone graft substitutes arise due to the advanced materials used (such as synthetic, allografts, and xenografts), complex procedures, and the need for skilled professionals. These costs can include the price of the graft material, surgical procedures, and post-operative care. This financial burden limits accessibility, particularly in developing regions or for uninsured patients. As a result, many individuals may delay or avoid treatment, hindering market growth.
Covid-19 Impact
The covid-19 pandemic significantly impacted the dental bone graft substitutes market by disrupting supply chains, delaying elective dental procedures, and limiting patient access to dental care. With lockdowns and health concerns, demand for dental treatments, including bone grafts, declined in the short term. However, as the situation improved and dental practices resumed normal operations, there was a resurgence in demand for bone graft substitutes, driven by increased awareness of oral health and the recovery of elective surgeries.
The allograft bone graft substitutes segment is expected to be the largest during the forecast period
The allograft bone graft substitutes segment is predicted to secure the largest market share throughout the forecast period. Allograft bone graft substitutes are materials derived from human cadaveric bone, typically processed to remove any living cells to reduce the risk of immune rejection. They serve as a scaffold for new bone growth in various orthopedic and dental procedures, such as dental implants and jaw reconstruction. The use of allografts reduces the need for additional surgery and donor site morbidity.
The dental implantology segment is expected to have the highest CAGR during the forecast period
The dental implantology segment is anticipated to witness the highest CAGR during the forecast period. In dental implantology, dental bone graft substitutes play a crucial role in enhancing the success of dental implants by providing structural support for implant placement in areas with insufficient or damaged bone. The use of bone graft substitutes in implantology is essential for improving outcomes in patients with bone loss due to trauma, periodontal disease, or congenital defects, enhancing overall implant success rates.
Asia Pacific is expected to register the largest market share during the forecast period driven by increasing dental healthcare awareness, rising disposable incomes, and a growing aging population. Countries like India, China, and Japan are key contributors due to their large patient base and improving access to advanced dental treatments. Additionally, government initiatives and the adoption of innovative biomaterials are expected to fuel market expansion in the region over the coming years.
North America is projected to witness the highest CAGR over the forecast period due to a high prevalence of dental issues, alongside an increasing demand for dental implants. The region benefits from advanced healthcare infrastructure, widespread awareness of oral health, and high disposable incomes. The United States, in particular, leads the market with significant demand for innovative bone graft materials like synthetic and allografts. Additionally, the adoption of minimally invasive dental procedures and technological advancements in biomaterials are expected to drive market growth in North America.
Key players in the market
Some of the key players profiled in the Dental Bone Graft Substitutes Market include Medtronic, Geistlich Pharma, Zimmer Biomet, Dentsply Sirona, Straumann Group, BioHorizons, Nobel Biocare, Ace Surgical Supply, RTI Surgical, Dentium, Botiss Biomaterials, Septodont, Osteogenics Biomedical, Biomatlante, Collagen Matrix, Implant Direct Sybron International, Institut Straumann, Maxigen Biotech, Sunstar Americas and Lifenet Health.
In October 2024, Geistlich Pharma launched the Bio-Oss(R) Pen, an applicator designed to improve the precision of its Bio-Oss(R) bone graft material application. This innovation aims to enhance user control, making it easier to apply the bone graft in minimally invasive surgeries and challenging clinical scenarios.
In October 2024, Nobel Biocare, in partnership with Mimetis Biomaterials, introduced creos(TM) syntogain, a biomimetic synthetic bone graft. Made of 80% calcium-deficient hydroxyapatite (CDHA) and 20% B-tricalcium phosphate, it closely mimics natural bone for enhanced osteoconduction and stability, intended to support efficient regeneration in dental procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.